NO942775D0 - 3-fenylureido-azepin-2-oner og -benzazepin-2-oner anvendelige som cholecystokinin-antagonister - Google Patents

3-fenylureido-azepin-2-oner og -benzazepin-2-oner anvendelige som cholecystokinin-antagonister

Info

Publication number
NO942775D0
NO942775D0 NO942775A NO942775A NO942775D0 NO 942775 D0 NO942775 D0 NO 942775D0 NO 942775 A NO942775 A NO 942775A NO 942775 A NO942775 A NO 942775A NO 942775 D0 NO942775 D0 NO 942775D0
Authority
NO
Norway
Prior art keywords
ones
benzazepin
phenylureido
azepin
useful
Prior art date
Application number
NO942775A
Other languages
English (en)
Other versions
NO942775L (no
Inventor
Iii John Adams Lowe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO942775D0 publication Critical patent/NO942775D0/no
Publication of NO942775L publication Critical patent/NO942775L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO942775A 1992-01-27 1994-07-26 3-fenylureido-azepin-2-oner og -benzazepin-2-oner anvendelige som cholecystokinin-antagonister NO942775L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27
PCT/US1992/010720 WO1993015059A1 (en) 1992-01-27 1992-12-16 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists

Publications (2)

Publication Number Publication Date
NO942775D0 true NO942775D0 (no) 1994-07-26
NO942775L NO942775L (no) 1994-09-20

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942775A NO942775L (no) 1992-01-27 1994-07-26 3-fenylureido-azepin-2-oner og -benzazepin-2-oner anvendelige som cholecystokinin-antagonister

Country Status (19)

Country Link
EP (1) EP0625145A1 (no)
JP (1) JPH07503465A (no)
KR (1) KR950700257A (no)
CN (1) CN1074903A (no)
AU (1) AU3276193A (no)
BR (1) BR9207071A (no)
CA (1) CA2117367A1 (no)
CZ (1) CZ391092A3 (no)
FI (1) FI943513A0 (no)
HU (1) HUT70496A (no)
IL (1) IL104472A0 (no)
MX (1) MX9300409A (no)
NO (1) NO942775L (no)
NZ (1) NZ245759A (no)
RU (1) RU94038063A (no)
TW (1) TW213901B (no)
WO (1) WO1993015059A1 (no)
YU (1) YU4393A (no)
ZA (1) ZA93582B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (es) * 1993-07-14 1997-04-01 Pfizer Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
US5618811A (en) * 1993-07-26 1997-04-08 Pfizer Inc. Tetrahydro-1H-benzazepinones and hexahydroazepinones as selective cholecystokinin-B receptor antagonists
WO1995014671A1 (en) * 1993-11-22 1995-06-01 Merck & Co., Inc. 3-acylaminobenzazepines
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
JP3030091B2 (ja) * 1994-10-04 2000-04-10 ファイザー・インコーポレーテッド 3−アミノ−ベンゾ[b]アゼピノンを製造するための方法および中間体
ES2171196T3 (es) * 1994-10-14 2002-09-01 Glaxosmithkline Spa Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño.
DE10153348A1 (de) 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte Benzo(b)azepin-2-on-Verbindungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
EP0625145A1 (en) 1994-11-23
TW213901B (no) 1993-10-01
BR9207071A (pt) 1995-12-05
KR950700257A (ko) 1995-01-16
HU9402195D0 (en) 1994-09-28
HUT70496A (en) 1995-10-30
YU4393A (sr) 1996-01-09
FI943513A (fi) 1994-07-26
ZA93582B (en) 1994-07-27
RU94038063A (ru) 1996-05-27
IL104472A0 (en) 1993-05-13
AU3276193A (en) 1993-09-01
JPH07503465A (ja) 1995-04-13
NO942775L (no) 1994-09-20
CZ391092A3 (en) 1994-01-19
CN1074903A (zh) 1993-08-04
NZ245759A (en) 1997-06-24
FI943513A0 (fi) 1994-07-26
WO1993015059A1 (en) 1993-08-05
CA2117367A1 (en) 1993-08-05
MX9300409A (es) 1993-07-01

Similar Documents

Publication Publication Date Title
FI931229A (fi) Som glanspigment laempade blandningar
FI934568A0 (fi) Hydrofobisitet som aostadkommits med metalljonaktivering
DE69400835D1 (de) Verschmutzungsverhindernde Substanz
FI931069A0 (fi) Kolloidalt rostat kaffe som aromatiseringsprodukt
FI934751A0 (fi) Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner
BR9304423A (pt) Ancora
NO954767D0 (no) 4-amino-17 delser som C17-20-lyase- og 5
NO942775D0 (no) 3-fenylureido-azepin-2-oner og -benzazepin-2-oner anvendelige som cholecystokinin-antagonister
FI930722A (fi) Foerfarande foer framstaellning av polymerer som innehaoller ammoniumgrupper
FI923709A (fi) I en saekerhetsskena laosbar vagn
FI934764A (fi) Anordning som hindrar krympning av kabelisolering
DK0640187T4 (da) Ankerfastg relse
ATA151292A (de) Beschlag
FI930219A (fi) Anvaendning av reaktionsblandningar som gjutbara massor
FI935826A0 (fi) Kallsmoerjmedel med delvis neutraliserade fosforsyraestrar som EP-tillsatsaemnen
ATA199692A (de) Schliessstück
ATA151392A (de) Beschlag
FI922527A (fi) Vaeggkonstruktion foer anordning i byggnader
DK0707579T3 (da) Piperidinylsubstituerede methanoanthracener som D1/D2-antagonister og 5 HT2-serotanin-antagonister
FI554U1 (fi) Reklam som aendrar faerg
FI922997A (fi) Tuggummi som innehaoller verksamma aemnen
SE9301471D0 (sv) New formulation
SE9201297D0 (sv) Synergistic combination
LV10417A (lv) Plaksnisu kede
FI930528A (fi) Luftkuddskonstruktion som passagerarskydd i fordon